scholarly article | Q13442814 |
P2093 | author name string | Changhong Xing | |
Eng H Lo | |||
P2860 | cites work | Receptors and transduction pathways for monocyte chemotactic protein-2 and monocyte chemotactic protein-3. Similarities and differences with MCP-1 | Q72332793 |
Proinflammatory cytokines and early neurological worsening in ischemic stroke | Q73048866 | ||
Characterization of binding sites for chemokines MCP-1 and MIP-1alpha on human brain microvessels | Q73081003 | ||
Microglia and macrophages are the major source of tumor necrosis factor in permanent middle cerebral artery occlusion in mice | Q73315270 | ||
Do transient ischemic attacks have a neuroprotective effect? | Q73889589 | ||
Neuroprotective activity of chemokines against N-methyl-D-aspartate or beta-amyloid-induced toxicity in culture | Q73964394 | ||
Evolution of cerebral tumor necrosis factor-alpha production during human ischemic stroke | Q74312789 | ||
Genome-wide gene expression analysis for induced ischemic tolerance and delayed neuronal death following transient global ischemia in rats | Q75347984 | ||
Tumor necrosis factor alpha serum levels and inflammatory response in acute ischemic stroke patients | Q75437705 | ||
Cultured rat microglia express functional beta-chemokine receptors | Q78074648 | ||
Expression of CCR2 by endothelial cells : implications for MCP-1 mediated wound injury repair and In vivo inflammatory activation of endothelium | Q78233810 | ||
Effects of proinflammatory cytokines on the growth, fate, and motility of multipotential neural precursor cells | Q79356172 | ||
Down-regulation of p27kip1 increases proliferation of progenitor cells in adult rats | Q80347390 | ||
Expression of immunoglobulin gene with classical V-(D)-J rearrangement in mouse brain neurons | Q80616208 | ||
Monocyte chemoattractant protein-1-induced angiogenesis is mediated by vascular endothelial growth factor-A | Q80894668 | ||
VEGF overexpression induces post-ischaemic neuroprotection, but facilitates haemodynamic steal phenomena | Q80918831 | ||
Membrane type 1-matrix metalloproteinase is regulated by chemokines monocyte-chemoattractant protein-1/ccl2 and interleukin-8/CXCL8 in endothelial cells during angiogenesis | Q80937048 | ||
Modulation of signal transducers and activators of transcription (STAT) factor pathways during focal cerebral ischaemia: a gene expression array study in rat hippocampus after middle cerebral artery occlusion | Q81321945 | ||
VEGF protects brain against focal ischemia without increasing blood--brain permeability when administered intracerebroventricularly | Q81649097 | ||
Release of exosomes from differentiated neurons and its regulation by synaptic glutamatergic activity | Q82634821 | ||
Expression and distribution of immunoglobulin G and its receptors in the human nervous system | Q82936962 | ||
Infusion of IL-10-expressing cells protects against renal ischemia through induction of lipocalin-2 | Q83326401 | ||
CXCL16 orchestrates adenosine A3 receptor and MCP-1/CCL2 activity to protect neurons from excitotoxic cell death in the CNS | Q83543271 | ||
CX3CL1 is up-regulated in the rat hippocampus during memory-associated synaptic plasticity | Q21129473 | ||
Divergent roles for tumor necrosis factor-alpha in the brain | Q23916360 | ||
MCP-1 (CCL2) protects human neurons and astrocytes from NMDA or HIV-tat-induced apoptosis | Q24301992 | ||
Functional expression of CCR2 by human fetal astrocytes | Q24307605 | ||
Discovery of a cytokine and its receptor by functional screening of the extracellular proteome | Q24310846 | ||
Functional overlap but differential expression of CSF-1 and IL-34 in their CSF-1 receptor-mediated regulation of myeloid cells | Q24315662 | ||
The lipocalin protein family: structure and function | Q24529878 | ||
CX3CL1 (fractalkine) and CX3CR1 expression in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis: kinetics and cellular origin. | Q24814510 | ||
Vascular endothelial growth factors (VEGFs) and stroke | Q26853592 | ||
The transcriptome of cerebral ischemia | Q27015999 | ||
Ligand preference inferred from the structure of neutrophil gelatinase associated lipocalin | Q27621524 | ||
The biology of VEGF and its receptors | Q27860704 | ||
Monocyte chemotactic protein (MCP)-1 promotes angiogenesis via a novel transcription factor, MCP-1-induced protein (MCPIP) | Q28115465 | ||
The MCP/eotaxin subfamily of CC chemokines | Q28137923 | ||
Expression of chemokines and their receptors in human and simian astrocytes: evidence for a central role of TNF alpha and IFN gamma in CXCR4 and CCR5 modulation | Q28205775 | ||
Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation | Q28240071 | ||
Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant | Q28252699 | ||
Highly regionalized neuronal expression of monocyte chemoattractant protein-1 (MCP-1/CCL2) in rat brain: evidence for its colocalization with neurotransmitters and neuropeptides | Q28262316 | ||
A new class of membrane-bound chemokine with a CX3C motif | Q28303204 | ||
Expression of monocyte chemoattractant protein-1 and macrophage inflammatory protein-1 after focal cerebral ischemia in the rat | Q28307447 | ||
Tumor necrosis factor (TNF)-mediated neuroprotection against glutamate-induced excitotoxicity is enhanced by N-methyl-D-aspartate receptor activation. Essential role of a TNF receptor 2-mediated phosphatidylinositol 3-kinase-dependent NF-kappa B pat | Q28507531 | ||
Control of microglial neurotoxicity by the fractalkine receptor | Q28513748 | ||
Fractalkine modulates TNF-alpha secretion and neurotoxicity induced by microglial activation | Q28564261 | ||
Lipocalin-2 is an autocrine mediator of reactive astrocytosis | Q28570404 | ||
Tumor necrosis factor α primes cerebral endothelial cells for erythropoietin-induced angiogenesis | Q28572003 | ||
Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia | Q28573077 | ||
Constitutive neuronal expression of CCR2 chemokine receptor and its colocalization with neurotransmitters in normal rat brain: functional effect of MCP-1/CCL2 on calcium mobilization in primary cultured neurons | Q28574923 | ||
Lipocalin 2 is present in the EAE brain and is modulated by natalizumab | Q36150875 | ||
Modulating inflammatory monocytes with a unique microRNA gene signature ameliorates murine ALS. | Q36190713 | ||
Higher plasma fractalkine is associated with better 6-month outcome from ischemic stroke. | Q36195292 | ||
Up-regulation of BDNF in astrocytes by TNF-alpha: a case for the neuroprotective role of cytokine | Q36253636 | ||
Visualization of chemokine binding sites on human brain microvessels | Q36256452 | ||
TLR9 bone marrow chimeric mice define a role for cerebral TNF in neuroprotection induced by CpG preconditioning | Q36459095 | ||
Lipocalin 2 is a novel regulator of angiogenesis in human breast cancer | Q36482942 | ||
Colony-stimulating factor 1 receptor (CSF1R) signaling in injured neurons facilitates protection and survival | Q36547694 | ||
Neuronal exosomal miRNA-dependent translational regulation of astroglial glutamate transporter GLT1. | Q36666203 | ||
Reactive astrocytes secrete lcn2 to promote neuron death | Q36673303 | ||
Preconditioning reprograms the response to ischemic injury and primes the emergence of unique endogenous neuroprotective phenotypes: a speculative synthesis | Q36721626 | ||
Chemokines and chemokine receptors in the brain: implication in neuroendocrine regulation | Q36752534 | ||
Differential roles of TNFR1 and TNFR2 signaling in adult hippocampal neurogenesis | Q36809040 | ||
Chemokines: a new class of neuromodulator? | Q36975766 | ||
Neuronal 'On' and 'Off' signals control microglia | Q36976861 | ||
Suppressed pro-inflammatory response of microglia in CX3CR1 knockout mice. | Q36984247 | ||
Role of lipocalin-2-chemokine axis in the development of neuropathic pain following peripheral nerve injury | Q37099774 | ||
Expression profiling of the cerebral ischemic and hypoxic response | Q37157844 | ||
Preconditioning and tolerance against cerebral ischaemia: from experimental strategies to clinical use. | Q37158226 | ||
Neural cells secrete a unique repertoire of proteins | Q37178891 | ||
Microglial clearance function in health and disease | Q37222916 | ||
VEGF receptor protein-tyrosine kinases: structure and regulation | Q37235450 | ||
Neutrophil gelatinase-associated lipocalin (NGAL) as a marker of kidney damage. | Q37251326 | ||
Neuron-derived IgG protects neurons from complement-dependent cytotoxicity | Q37343400 | ||
Pro-inflammatory cytokine TNF-alpha as a neuroprotective agent in the brain. | Q37359456 | ||
Involvement of TRPC channels in CCL2-mediated neuroprotection against tat toxicity | Q37401453 | ||
The FGF-2/FGFRs neurotrophic system promotes neurogenesis in the adult brain. | Q37416408 | ||
Neuron-glia crosstalk in health and disease: fractalkine and CX3CR1 take centre stage | Q37424844 | ||
Vascular endothelial growth factor: direct neuroprotective effect in in vitro ischemia | Q37441879 | ||
Neutrophil gelatinase-associated lipocalin (NGAL) in human neoplasias: a new protein enters the scene | Q37525013 | ||
Human, mouse, and rat genome large-scale rearrangements: stability versus speciation | Q37593036 | ||
The two different receptors for tumor necrosis factor mediate distinct cellular responses | Q37609601 | ||
IL-34 is a tissue-restricted ligand of CSF1R required for the development of Langerhans cells and microglia | Q37615661 | ||
Increased systemic and myocardial expression of neutrophil gelatinase-associated lipocalin in clinical and experimental heart failure | Q28575465 | ||
Fractalkine and CX 3 CR1 regulate hippocampal neurogenesis in adult and aged rats | Q28576101 | ||
Vascular endothelial growth factor (VEGF) stimulates neurogenesis in vitro and in vivo | Q28577046 | ||
VEGF links hippocampal activity with neurogenesis, learning and memory | Q28578381 | ||
Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice | Q28593600 | ||
Vascular endothelial growth factor is a secreted angiogenic mitogen | Q28646475 | ||
How dying cells alert the immune system to danger | Q29615501 | ||
Neuronal replacement from endogenous precursors in the adult brain after stroke | Q29615772 | ||
Fate mapping analysis reveals that adult microglia derive from primitive macrophages | Q29616177 | ||
Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid | Q29617640 | ||
Gene-expression profiles and transcriptional regulatory pathways that underlie the identity and diversity of mouse tissue macrophages | Q29620142 | ||
A lineage of myeloid cells independent of Myb and hematopoietic stem cells | Q29620147 | ||
Phagocytic activity of neuronal progenitors regulates adult neurogenesis | Q30426473 | ||
Pannexin 1 channels mediate 'find-me' signal release and membrane permeability during apoptosis | Q30432676 | ||
Find-me and eat-me signals in apoptotic cell clearance: progress and conundrums | Q30433111 | ||
Chemokines as mediators of neovascularization | Q30438032 | ||
CX3CR1 deficiency leads to impairment of hippocampal cognitive function and synaptic plasticity | Q30467724 | ||
VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain | Q30936721 | ||
Vascular endothelial growth factor antagonist reduces brain edema formation and venous infarction | Q30989261 | ||
Cellular localization of tumor necrosis factor alpha following focal cerebral ischemia in mice | Q32026749 | ||
TNF-alpha stimulates caspase-3 activation and apoptotic cell death in primary septo-hippocampal cultures. | Q33181856 | ||
MCP-1 induces migration of adult neural stem cells. | Q33208324 | ||
Global similarity and local divergence in human and mouse gene co-expression networks | Q33257304 | ||
Tumor necrosis factor alpha triggers proliferation of adult neural stem cells via IKK/NF-kappaB signaling | Q33258175 | ||
Gene expression patterns in mouse cortical penumbra after focal ischemic brain injury and reperfusion | Q33338114 | ||
Enhanced detection of CNS cell secretome in plasma protein-depleted cerebrospinal fluid | Q33367344 | ||
Cystatin C is released in association with exosomes: a new tool of neuronal communication which is unbalanced in Alzheimer's disease. | Q33505900 | ||
Molecular dialogs between the ischemic brain and the peripheral immune system: dualistic roles in injury and repair | Q33583258 | ||
FGF-2 released from degenerating neurons exerts microglial-induced neuroprotection via FGFR3-ERK signaling pathway | Q33616048 | ||
CSF-1 receptor signaling in myeloid cells | Q33653719 | ||
Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury | Q33830710 | ||
Tumor necrosis factors alpha and beta protect neurons against amyloid beta-peptide toxicity: evidence for involvement of a kappa B-binding factor and attenuation of peroxide and Ca2+ accumulation. | Q33900383 | ||
Neuronal production of lipocalin-2 as a help-me signal for glial activation | Q34004153 | ||
Lipocalin-2 deficiency attenuates neuroinflammation and brain injury after transient middle cerebral artery occlusion in mice | Q34018660 | ||
Modulating neurotoxicity through CX3CL1/CX3CR1 signaling | Q34019783 | ||
Dynamic variation of genes profiles and pathways in the hippocampus of ischemic mice: a genomic study | Q44822580 | ||
Lipocalin 2 is a novel immune mediator of experimental autoimmune encephalomyelitis pathogenesis and is modulated in multiple sclerosis | Q45037418 | ||
Production and in vivo effects of chemokines CXCL1-3/KC and CCL2/JE in a model of inflammatory angiogenesis in mice. | Q45186058 | ||
Monocyte chemoattractant protein-1 regulation of blood-brain barrier permeability | Q45250155 | ||
CX3CL1 is neuroprotective in permanent focal cerebral ischemia in rodents | Q45325019 | ||
Anti-monocyte chemoattractant protein-1 gene therapy protects against focal brain ischemia in hypertensive rats | Q45880342 | ||
Long term exposure to the chemokine CCL2 activates the nigrostriatal dopamine system: a novel mechanism for the control of dopamine release. | Q45992275 | ||
Circulating antibody against tumor necrosis factor-alpha protects rat brain from reperfusion injury | Q46080372 | ||
Astrocyte-derived MCP-1 mediates neuroprotective effects of noradrenaline. | Q46171858 | ||
Stimulation of microglial metabotropic glutamate receptor mGlu2 triggers tumor necrosis factor alpha-induced neurotoxicity in concert with microglial-derived Fas ligand. | Q46384476 | ||
Tumor necrosis factor-alpha modulates survival, proliferation, and neuronal differentiation in neonatal subventricular zone cell cultures | Q46516178 | ||
The neuroprotection of prodromal transient ischaemic attack on cerebral infarction | Q46573727 | ||
VEGF-overexpressing transgenic mice show enhanced post-ischemic neurogenesis and neuromigration | Q46594906 | ||
Tumor necrosis factor-alpha and interleukin-18 modulate neuronal cell fate in embryonic neural progenitor culture | Q46626966 | ||
Effect of hypoxic preconditioning on brain genomic response before and following ischemia in the adult mouse: identification of potential neuroprotective candidates for stroke | Q46751261 | ||
Transient ischemic attacks before ischemic stroke: preconditioning the human brain? A multicenter magnetic resonance imaging study | Q47205226 | ||
Potential role of MCP-1 in endothelial cell tight junction 'opening': signaling via Rho and Rho kinase | Q47425860 | ||
Reduction of ischemic damage by application of vascular endothelial growth factor in rat brain after transient ischemia | Q47696803 | ||
Vascular endothelial growth factor expression in transient focal cerebral ischemia in the rat. | Q47772427 | ||
Localization of fractalkine and CX3CR1 mRNAs in rat brain: does fractalkine play a role in signaling from neuron to microglia? | Q47895908 | ||
Effects of monocyte chemoattractant protein 1 on blood-borne cell recruitment after transient focal cerebral ischemia in mice | Q47990486 | ||
Neuronal expression of fractalkine in the presence and absence of inflammation. | Q48003297 | ||
Tumor necrosis factor-alpha expression in ischemic neurons | Q48094066 | ||
Intraventricular vascular endothelial growth factor antibody increases infarct volume following transient cerebral ischemia | Q48133360 | ||
Chemokine ligand 2 (CCL2) induces migration and differentiation of subventricular zone cells after stroke | Q48163628 | ||
Differential production of MCP-1 and cytokine-induced neutrophil chemoattractant in the ischemic brain after transient focal ischemia in rats | Q48179025 | ||
Effect of ischaemic preconditioning on genomic response to cerebral ischaemia: similarity to neuroprotective strategies in hibernation and hypoxia-tolerant states | Q48182556 | ||
Cell type specific upregulation of vascular endothelial growth factor in an MCA-occlusion model of cerebral infarct | Q48182992 | ||
Fc receptor for IgG (FcR) on rat microglia | Q48195817 | ||
Ischemic tolerance due to the induction of HSP70 in a rat ischemic recirculation model | Q48250472 | ||
Absence of the chemokine receptor CCR2 protects against cerebral ischemia/reperfusion injury in mice | Q48255913 | ||
Production and neuroprotective functions of fractalkine in the central nervous system | Q48258224 | ||
Endotoxin preconditioning protects against the cytotoxic effects of TNFalpha after stroke: a novel role for TNFalpha in LPS-ischemic tolerance | Q48258831 | ||
Induction of cerebral ischemic tolerance by erythromycin preconditioning reprograms the transcriptional response to ischemia and suppresses inflammation | Q48260107 | ||
Overexpression of monocyte chemoattractant protein 1 in the brain exacerbates ischemic brain injury and is associated with recruitment of inflammatory cells | Q48285984 | ||
Acute inflammation initiates the regenerative response in the adult zebrafish brain. | Q48302679 | ||
Monocyte chemoattractant protein-1 plays a critical role in neuroblast migration after focal cerebral ischemia. | Q48326932 | ||
Effects of anti-VEGF antibody on blood-brain barrier disruption in focal cerebral ischemia | Q48328488 | ||
Ischemic and excitotoxic brain injury is enhanced in mice lacking the p55 tumor necrosis factor receptor | Q48331119 | ||
What is immune privilege (not)? | Q48356667 | ||
Quantitative proteomic analysis reveals protein expression changes in the murine neuronal secretome during apoptosis | Q48363922 | ||
Increasing levels of leukocyte-derived inflammatory mediators in plasma and cAMP in platelets during follow-up after acute cerebral ischemia | Q48374503 | ||
Cellular expression of tumor necrosis factor a and its receptors in human ischemic stroke. | Q48374627 | ||
VEGF overexpression enhances striatal neurogenesis in brain of adult rat after a transient middle cerebral artery occlusion | Q48388791 | ||
Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) following permanent and transient occlusion of the middle cerebral artery in the rat. | Q48395559 | ||
Effects of intraventricular infusion of vascular endothelial growth factor on cerebral blood flow, edema, and infarct volume | Q48402018 | ||
DNA microarray analysis of cortical gene expression during early recirculation after focal brain ischemia in rat. | Q48427055 | ||
Tumour necrosis factor-alpha impairs neuronal differentiation but not proliferation of hippocampal neural precursor cells: Role of Hes1. | Q48429836 | ||
Vascular endothelial growth factor improves recovery of sensorimotor and cognitive deficits after focal cerebral ischemia in the rat. | Q48439329 | ||
Nicotine blocks TNF-alpha-mediated neuroprotection to NMDA by an alpha-bungarotoxin-sensitive pathway | Q48483670 | ||
Brain genomic response following hypoxia and re-oxygenation in the neonatal rat. Identification of genes that might contribute to hypoxia-induced ischemic tolerance | Q48530031 | ||
Tumor necrosis factor-alpha mediated signaling in neuronal homeostasis and dysfunction | Q37680121 | ||
Quantitative neuroproteomics: classical and novel tools for studying neural differentiation and function | Q37721307 | ||
The role of monocyte chemoattractant protein MCP1/CCL2 in neuroinflammatory diseases. | Q37777395 | ||
Tumor necrosis factor-alpha and the roles it plays in homeostatic and degenerative processes within the central nervous system | Q37897498 | ||
The divergent receptors for TNF. | Q37900017 | ||
Effects of vascular endothelial growth factor in ischemic stroke | Q38020128 | ||
TNFα in synaptic function: switching gears. | Q38022998 | ||
Colony stimulating factors and myeloid cell biology in health and disease. | Q38045643 | ||
FLT4/VEGFR3 and Milroy disease: novel mutations, a review of published variants and database update. | Q38052872 | ||
Genetics and genomics of ischemic tolerance: focus on cardiac and cerebral ischemic preconditioning | Q38061499 | ||
Current status of chemokines in the adult CNS. | Q38085956 | ||
Demyelination and other neurological adverse events after anti-TNF therapy | Q38137583 | ||
Fibroblast growth factor-2 signaling in neurogenesis and neurodegeneration. | Q38140658 | ||
Endogenous brain protection: what the cerebral transcriptome teaches us. | Q38203067 | ||
Microglia and brain macrophages in the molecular age: from origin to neuropsychiatric disease | Q38203104 | ||
Vascular endothelial growth factor: therapeutic possibilities and challenges for the treatment of ischemia. | Q38252869 | ||
The heparin-binding (fibroblast) growth factor family of proteins | Q38286731 | ||
Microarray analysis of hippocampal gene expression in global cerebral ischemia | Q38298966 | ||
A nuclear odyssey: fibroblast growth factor-2 (FGF-2) as a regulator of nuclear homeostasis in the nervous system. | Q38304823 | ||
Parallel gene expression monitoring using oligonucleotide probe arrays of multiple transcripts with an animal model of focal ischemia | Q38310312 | ||
CCL2 regulates angiogenesis via activation of Ets-1 transcription factor | Q38310933 | ||
Fractalkine-upregulated milk-fat globule EGF factor-8 protein in cultured rat microglia | Q38330638 | ||
TNFR1 upregulation mediates tolerance after brain ischemic preconditioning. | Q38332109 | ||
Overexpression of genes in the CA1 hippocampus region of adult rat following episodes of global ischemia | Q38337860 | ||
DNA Microarray Analysis of Hippocampal Gene Expression Measured Twelve Hours after Hypoxia-Ischemia in the Mouse | Q38349629 | ||
Genomics of the periinfarction cortex after focal cerebral ischemia | Q38352866 | ||
Genomic response of the rat brain to global ischemia and reperfusion. | Q38511556 | ||
Pathway and gene ontology based analysis of gene expression in a rat model of cerebral ischemic tolerance | Q38515327 | ||
Global gene expression in the developing rat brain after hypoxic preconditioning: involvement of apoptotic mechanisms? | Q38516167 | ||
Microvesicles in the brain: Biomarker, messenger or mediator? | Q38623975 | ||
Lipocalin 2 in the central nervous system host response to systemic lipopolysaccharide administration | Q38695122 | ||
Exosomes and other extracellular vesicles in neural cells and neurodegenerative diseases | Q38732218 | ||
Communication by Extracellular Vesicles: Where We Are and Where We Need to Go. | Q38769897 | ||
Lipocalin-2 enhances angiogenesis in rat brain endothelial cells via reactive oxygen species and iron-dependent mechanisms | Q38923476 | ||
MFG-E8 regulates microglial phagocytosis of apoptotic neurons | Q39429140 | ||
Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice | Q39714957 | ||
Microglia emerge from erythromyeloid precursors via Pu.1- and Irf8-dependent pathways | Q34035175 | ||
Monocyte chemoattractant protein-1-deficiency impairs the expression of IL-6, IL-1β and G-CSF after transient focal ischemia in mice | Q34059585 | ||
Regulation of monocyte chemoattractant protein-1 expression in adult human non-neoplastic astrocytes is sensitive to tumor necrosis factor (TNF) or antibody to the 55-kDa TNF receptor | Q34061207 | ||
Systemic lipopolysaccharide protects the brain from ischemic injury by reprogramming the response of the brain to stroke: a critical role for IRF3 | Q34160637 | ||
Role of chemokines in CNS health and pathology: a focus on the CCL2/CCR2 and CXCL8/CXCR2 networks | Q34170906 | ||
Cues for apoptotic cell engulfment: eat-me, don't eat-me and come-get-me signals | Q34277619 | ||
Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. | Q34306146 | ||
Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses. | Q34324135 | ||
Tumor necrosis factor type alpha, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo | Q34333796 | ||
VEGF receptor signal transduction | Q34461939 | ||
Fractalkine attenuates excito-neurotoxicity via microglial clearance of damaged neurons and antioxidant enzyme heme oxygenase-1 expression | Q34503290 | ||
TNF-α affects human cortical neural progenitor cell differentiation through the autocrine secretion of leukemia inhibitory factor | Q34510498 | ||
Spatial and temporal gene expression differences in core and periinfarct areas in experimental stroke: a microarray analysis. | Q34533044 | ||
Reprogramming the response to stroke by preconditioning | Q34555863 | ||
CX3CL1 reduces neurotoxicity and microglial activation in a rat model of Parkinson's disease. | Q34576624 | ||
The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing | Q34582371 | ||
Stress-induced lipocalin-2 controls dendritic spine formation and neuronal activity in the amygdala. | Q34674514 | ||
Neuron-derived IgG protects dopaminergic neurons from insult by 6-OHDA and activates microglia through the FcγR I and TLR4 pathways | Q34780985 | ||
Fetal brain genomic reprogramming following asphyctic preconditioning | Q34783651 | ||
Serum levels of the MCP-1 chemokine in patients with ischemic stroke and myocardial infarction. | Q34894419 | ||
Stroma-derived interleukin-34 controls the development and maintenance of langerhans cells and the maintenance of microglia | Q34918881 | ||
Microglia as a source and target of cytokines | Q34963658 | ||
Multiple preconditioning paradigms converge on interferon regulatory factor-dependent signaling to promote tolerance to ischemic brain injury. | Q35088789 | ||
Fibroblast growth factor receptor tyrosine kinases: molecular analysis and signal transduction | Q35229509 | ||
Interleukin-34 selectively enhances the neuroprotective effects of microglia to attenuate oligomeric amyloid-β neurotoxicity | Q35235779 | ||
Neurogenesis in dentate subgranular zone and rostral subventricular zone after focal cerebral ischemia in the rat | Q35298897 | ||
Interleukin-34 restores blood-brain barrier integrity by upregulating tight junction proteins in endothelial cells. | Q35533000 | ||
Lipocalin-2 controls neuronal excitability and anxiety by regulating dendritic spine formation and maturation | Q35546789 | ||
Inhibition of NF-kappaB potentiates amyloid beta-mediated neuronal apoptosis | Q35606094 | ||
Unraveling the ischemic brain transcriptome in a permanent middle cerebral artery occlusion mouse model by DNA microarray analysis | Q35794591 | ||
Coexpression of angiopoietin-1 with VEGF increases the structural integrity of the blood-brain barrier and reduces atrophy volume | Q35880577 | ||
Tissue-type plasminogen activator has a neuroprotective effect in the ischemic brain mediated by neuronal TNF-α. | Q35880850 | ||
The CCR2/CCL2 interaction mediates the transendothelial recruitment of intravascularly delivered neural stem cells to the ischemic brain | Q36020853 | ||
Lipocalin 2: novel component of proinflammatory signaling in Alzheimer's disease | Q36055547 | ||
VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia | Q39774417 | ||
The temporal profile of inflammatory markers and mediators in blood after acute ischemic stroke differs depending on stroke outcome | Q39871785 | ||
Role of monocyte chemoattractant protein-1 (MCP-1/CCL2) in migration of neural progenitor cells toward glial tumors. | Q39898344 | ||
The role of TNF-alpha and its receptors in the production of NGF and GDNF by astrocytes | Q40234978 | ||
The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF. | Q40241912 | ||
The yin-yang nature of CSF1R-binding cytokines. | Q40280062 | ||
IgG-immunostaining in the intact rabbit brain: variable but significant staining of hippocampal and cerebellar neurons with anti-IgG. | Q40622375 | ||
Hyperthermia induces 72kDa heat shock protein expression in rat brain in non-neuronal cells | Q40712922 | ||
VEGF antagonism reduces edema formation and tissue damage after ischemia/reperfusion injury in the mouse brain | Q40857831 | ||
Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression | Q40868885 | ||
Expression of multiple functional chemokine receptors and monocyte chemoattractant protein-1 in human neurons | Q40877325 | ||
Tumor necrosis factor is a brain damaging cytokine in cerebral ischemia | Q40878286 | ||
Regulation of GDNF expression in cultured astrocytes by inflammatory stimuli | Q41082615 | ||
Attenuated stroke severity after prodromal TIA: a role for ischemic tolerance in the brain? | Q41604222 | ||
Interleukin-34 promotes tumor progression and metastatic process in osteosarcoma through induction of angiogenesis and macrophage recruitment | Q41730916 | ||
Expression of TNF and TNF receptors (p55 and p75) in the rat brain after focal cerebral ischemia | Q41941905 | ||
Suppression of stroke-induced progenitor proliferation in adult subventricular zone by tumor necrosis factor receptor 1. | Q42436364 | ||
CX3CL1 and CX3CR1 expression in human brain tissue: noninflammatory control versus multiple sclerosis | Q42451178 | ||
Tumor necrosis factor receptor 1 is a negative regulator of progenitor proliferation in adult hippocampal neurogenesis. | Q42501630 | ||
Tumor necrosis factor stimulates the synthesis and secretion of biologically active nerve growth factor in non-neuronal cells. | Q42811916 | ||
Recombinant adeno-associated virus serotype 1-vascular endothelial growth factor promotes neurogenesis and neuromigration in the subventricular zone and rescues neuronal function in ischemic rats | Q43260398 | ||
Lipopolysaccharide-induced ischemic tolerance is associated with increased levels of ceramide in brain and in plasma | Q43548448 | ||
Vascular endothelial growth factor rescues hippocampal neurons from glutamate-induced toxicity: signal transduction cascades. | Q43601730 | ||
Neurodegenerative and neuroprotective effects of tumor Necrosis factor (TNF) in retinal ischemia: opposite roles of TNF receptor 1 and TNF receptor 2. | Q43935582 | ||
Neuron-microglia crosstalk up-regulates neuronal FGF-2 expression which mediates neuroprotection against excitotoxicity via JNK1/2. | Q43972655 | ||
Tolerance against ischemic neuronal injury can be induced by volatile anesthetics and is inducible NO synthase dependent | Q44053948 | ||
Angiopoietin-1 reduces cerebral blood vessel leakage and ischemic lesion volume after focal cerebral embolic ischemia in mice | Q44084442 | ||
Vascular endothelial growth factor protects cultured rat hippocampal neurons against hypoxic injury via an antiexcitotoxic, caspase-independent mechanism | Q44170835 | ||
Rat forebrain neurogenesis and striatal neuron replacement after focal stroke | Q44226820 | ||
Decreased levels of plasma vitamin C and increased concentrations of inflammatory and oxidative stress markers after stroke | Q44690384 | ||
Chemokine receptors are expressed widely by embryonic and adult neural progenitor cells | Q44817634 | ||
Secretome protein enrichment identifies physiological BACE1 protease substrates in neurons | Q36103683 | ||
The neural cell adhesion molecules L1 and CHL1 are cleaved by BACE1 protease in vivo | Q36122127 | ||
Fractalkine and CX3CR1 are involved in the migration of intravenously grafted human bone marrow stromal cells toward ischemic brain lesion in rats | Q48547193 | ||
Effect of ischemic preconditioning on the expression of putative neuroprotective genes in the rat brain | Q48556658 | ||
Genomic responses of the brain to ischemic stroke, intracerebral haemorrhage, kainate seizures, hypoglycemia, and hypoxia | Q48559379 | ||
Distribution, cellular localization and functional role of CCR2 chemokine receptors in adult rat brain | Q48579984 | ||
Gene expression analysis to identify molecular correlates of pre- and post-conditioning derived neuroprotection | Q48587981 | ||
Rapid induction of vascular endothelial growth factor gene expression after transient middle cerebral artery occlusion in rats | Q48613015 | ||
Mice deficient in fractalkine are less susceptible to cerebral ischemia-reperfusion injury | Q48627196 | ||
Ephrin-A3 and ephrin-A4 contribute to microglia-induced angiogenesis in brain endothelial cells | Q48632619 | ||
Monocyte chemoattractant protein-1 deficiency is protective in a murine stroke model | Q48663782 | ||
Tumor necrosis factor-alpha. A mediator of focal ischemic brain injury | Q48698077 | ||
Induction of tumor necrosis factor-alpha in the mouse hippocampus following transient forebrain ischemia | Q48714125 | ||
TNF-alpha pretreatment induces protective effects against focal cerebral ischemia in mice | Q48714135 | ||
Early TNF-alpha levels correlate with ischaemic stroke severity | Q48720718 | ||
Monocyte chemoattractant protein-1 is increased in the cerebrospinal fluid of patients with ischemic stroke | Q48721929 | ||
Differential and time-dependent expression of monocyte chemoattractant protein-1 mRNA by astrocytes and macrophages in rat brain: effects of ischemia and peripheral lipopolysaccharide administration | Q48743383 | ||
Effects of the chemokine CCL2 on blood-brain barrier permeability during ischemia-reperfusion injury | Q48761475 | ||
Microglia protect neurons against ischemia by synthesis of tumor necrosis factor. | Q48767062 | ||
TNF-alpha antibody infusion impairs survival of stroke-generated neuroblasts in adult rat brain | Q48770988 | ||
Lipopolysaccharide pre-treatment induces resistance against subsequent focal cerebral ischemic damage in spontaneously hypertensive rats | Q48799531 | ||
Monocyte chemoattractant protein-1 expressed in neurons and astrocytes during focal ischemia in mice | Q48862259 | ||
Inhibition of tumor necrosis factor-alpha reduces focal cerebral ischemic injury in the spontaneously hypertensive rat. | Q48887459 | ||
Preconditioning effects of tumor necrosis factor-α and glutamate on calcium dynamics in rat organotypic hippocampal cultures | Q48892135 | ||
'Ischemic tolerance' phenomenon found in the brain | Q48895274 | ||
VEGF and flt. Expression time kinetics in rat brain infarct | Q48910869 | ||
Leukocyte activation detected by increased plasma levels of inflammatory mediators in patients with ischemic cerebrovascular diseases | Q48910989 | ||
Stress proteins and tolerance to focal cerebral ischemia | Q48969161 | ||
Localization of monocyte chemoattractant peptide-1 expression in the central nervous system in experimental autoimmune encephalomyelitis and trauma in the rat. | Q48987538 | ||
Expression of tumor necrosis factor alpha after focal cerebral ischaemia in the rat. | Q49077164 | ||
Immunohistochemical analysis of CCR2, CCR3, CCR5, and CXCR4 in the human brain: potential mechanisms for HIV dementia | Q49156145 | ||
Expression and localization of the iron-siderophore binding protein lipocalin 2 in the normal rat brain and after kainate-induced excitotoxicity. | Q49157594 | ||
Role of CX3CR1 (fractalkine receptor) in brain damage and inflammation induced by focal cerebral ischemia in mouse | Q49160789 | ||
Intraventricular infusion of vascular endothelial growth factor promotes cerebral angiogenesis with minimal brain edema. | Q50501492 | ||
Monocyte chemoattractant protein-1-deficiency results in altered blood-brain barrier breakdown after experimental stroke. | Q50862254 | ||
Genomics of preconditioning. | Q53633445 | ||
Induction of natural killer cell migration by monocyte chemotactic protein−1, −2 and −3 | Q56943553 | ||
Expression of Neutrophil Gelatinase–Associated Lipocalin in Atherosclerosis and Myocardial Infarction | Q57607666 | ||
Microarray analysis of acute and delayed gene expression profile in rats after focal ischemic brain injury and reperfusion | Q57997611 | ||
Fibroblast growth factor-2 induces astroglial and microglial reactivity in vivo | Q58456409 | ||
The release of tumor necrosis factor-α is associated with ischemic tolerance in human stroke | Q60589568 | ||
Induction of inflammatory angiogenesis by monocyte chemoattractant protein-1 | Q61773870 | ||
Lipocalin 2 Plays an Immunomodulatory Role and Has Detrimental Effects after Spinal Cord Injury | Q63915714 | ||
VEGF-Induced BBB Permeability is Associated with an MMP-9 Activity Increase in Cerebral ischemia: Both Effects Decreased by ANG-1 | Q63966767 | ||
Vascular permeability factor, an endothelial cell mitogen related to PDGF | Q69116052 | ||
Chemokine monocyte chemoattractant protein-1 is expressed by astrocytes after mechanical injury to the brain | Q71151706 | ||
Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors | Q71169977 | ||
Tumor necrosis factors protect neurons against metabolic-excitotoxic insults and promote maintenance of calcium homeostasis | Q71607261 | ||
Production and function of monocyte chemoattractant protein-1 and other β-chemokines in murine glial cells | Q71977731 | ||
Tumor necrosis factor alpha and transforming growth factor beta upregulate astrocyte expression of monocyte chemoattractant protein-1 | Q72132484 | ||
Monocyte chemoattractant protein-1 messenger RNA expression in rat ischemic cortex | Q72139366 | ||
P304 | page(s) | 181-199 | |
P577 | publication date | 2016-04-11 | |
P1433 | published in | Progress in Neurobiology | Q15716615 |
P1476 | title | Help-me signaling: Non-cell autonomous mechanisms of neuroprotection and neurorecovery | |
P478 | volume | 152 |
Q55224821 | A potential gliovascular mechanism for microglial activation: differential phenotypic switching of microglia by endothelium versus astrocytes. |
Q28078362 | Clearing the corpses: regulatory mechanisms, novel tools, and therapeutic potential of harnessing microglial phagocytosis in the diseased brain |
Q38751291 | Cystatin C as a potential therapeutic mediator against Parkinson's disease via VEGF-induced angiogenesis and enhanced neuronal autophagy in neurovascular units |
Q48218865 | Extracellular Mitochondria in Cerebrospinal Fluid and Neurological Recovery After Subarachnoid Hemorrhage. |
Q93049974 | Eye Opener in Stroke |
Q92587953 | Is there a central role for the cerebral endothelium and the vasculature in the brain response to conditioning stimuli? |
Q58716193 | Molecular Communication of a Dying Neuron in Stroke |
Q92895839 | Neuron-generated thrombin induces a protective astrocyte response via protease activated receptors |
Q104795162 | Neuronal extracellular vesicle derived miR-98 prevents salvageable neurons from microglial phagocytosis in acute ischemic stroke |
Q50117414 | Neuroprotective Effects of Bioactive Compounds and MAPK Pathway Modulation in "Ischemia"-Stressed PC12 Pheochromocytoma Cells. |
Q93097933 | Promoting Neuro-Supportive Properties of Astrocytes with Epidermal Growth Factor Hydrogels |
Q88748094 | Protective Effects of Endothelial Progenitor Cell-Derived Extracellular Mitochondria in Brain Endothelium |
Q47924784 | Role of Carbon Monoxide in Neurovascular Repair Processing |
Q47093776 | Systemic Inflammation-Associated Proteins and Retinopathy of Prematurity in Infants Born Before the 28th Week of Gestation |
Q89934562 | The effects of A1/A2 astrocytes on oligodendrocyte linage cells against white matter injury under prolonged cerebral hypoperfusion |
Q34535591 | Transfer of mitochondria from astrocytes to neurons after stroke |
Search more.